Psycheceutical: Funding, Investors & Team (Sep 2026)
Psycheceutical is a patented delivery technology that provides safe bioavailable psychedelic pharmaceutical medicines. Their goal is to employ next-generation patented Janus particles and novel delivery technologies to bring safety and efficacy to psychedelic compounds for the medical and pharmaceutical industries. These advanced delivery systems allow for safe dosage control and consistent desired results.
Psycheceutical has raised $600k across 3 funding rounds on record, the most recent an undisclosed round of $100k announced in Jul 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Psycheceutical Company Profile and Key Stats
Latest funding round on record: Jul 2024.
Psycheceutical Funding Rounds
Psycheceutical raised $400k in a Seed announced in Oct 2021.
5 months later, a Seed of $100k was announced in Mar 2022.
2.3 years later, an undisclosed round of $100k was announced in Jul 2024.
Psycheceutical Founders and Leadership Team
Contact details for the Psycheceutical team: 1 of 2 have an email address on file.
Start 14-day free trial →Psycheceutical Funding Compared to Other Biotechnology Startups
Psycheceutical's latest round of $100k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Psycheceutical in Biotechnology and Fort Lauderdale
Companies Similar to Psycheceutical
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Psycheceutical Funding FAQs
What does Psycheceutical do?
Psycheceutical is a patented delivery technology that provides safe bioavailable psychedelic pharmaceutical medicines. Their goal is to employ next-generation patented Janus particles and novel delivery technologies to bring safety and efficacy to psychedelic compounds for the medical and pharmaceutical industries. These advanced delivery systems allow for safe dosage control and consistent desired results.
How much funding has Psycheceutical raised?
Psycheceutical has raised $600k across 3 rounds on record. The most recent is an undisclosed round of $100k announced in Jul 2024.
When did Psycheceutical last raise funding?
Psycheceutical's most recent funding round on record is an undisclosed round of $100k, announced in Jul 2024.
Who founded Psycheceutical?
FundedIQ lists James Martin (Founder) at Psycheceutical.
Who is the CEO of Psycheceutical?
Chad Harman is listed as CEO at Psycheceutical.
Where is Psycheceutical headquartered?
Psycheceutical is based in Fort Lauderdale, Florida, United States.
How many employees does Psycheceutical have?
Psycheceutical is in the 11-50 employee band.
How does Psycheceutical's funding compare to other Biotechnology startups?
Psycheceutical's latest round of $100k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Psycheceutical Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Psycheceutical is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.